Abstract:Background. Ischemic acute renal failure (ARF) is a common and often fatal condition characterized by tubular epithelial cell necrosis and marked monocyte infiltration. Inflammatory mechanisms, including cell adhesion, cell infiltration, and cytokine production, are involved. These processes are thought to be directly or indirectly regulated by nuclear factor kappaB (NF-kappaB). Targeted of NF-kappaB might ameliorate ischemia/ reperfusion (I/R) injury by inhibiting the production of genes that involved in ischemic ARF. The objective of the present study was to evaluate the effect of NF-kappaB decoy oligodeoxynucleotides (ODN) in experimental rat ischemic ARF.Methods. Ischemic ARF was induced by left renal artery clamping for 60 minutes, while the right kidney was being removed in female Sprague-Dawley rats. The effect of cationic liposome-protamine-NF-kappaB decoy ODN was evaluated after infusion into the kidney via the renal artery before clamping. After 24 hours of reperfusion, we then assessed morphologic and functional parameters, NF-kappaB/DNA binding activity, monocyte/macrophage (M/MPhi) infiltration, and gene expression in I/R kidney.Results. After 24 hours of reperfusion, compared with sham-operated animals, serum creatinine and blood urea nitrogen (BUN) levels in ischemic ARF animals were increased about 10-fold and fivefold respectively. (255.67 +/- 34.48 mumol/L vs. 25.33 +/- 2.23 mumol/L and 43.47 +/- 5.50 mmol/L vs. 8.45 +/- 0.43 mmol/L, P < 0.001), NF-kappa B/DNA binding activity was markedly elevated [median value was 1.75 vs. 0.15 relative density unit (RDU), P < 0.005]. NF-kappaB decoy ODN treatment reduced the elevation of serum creatinine level by 70% (79.17 +/- 8.64 mumol/L vs. 255.67 +/- 34.48 mumol/L, P < 0.01), BUN level by 40% (28.33 =/- 4.86 mmol/L vs. 43.47 +/- 5.50 mmol/L, P = NS), and almost abolished the NF-kappa B activation compared with levels observed in sham-operated rats (median value was 0.25 vs. 1.9 RDU, P < 0.005). Furthermore, NF-kappaB decoy ODN pretreatment prevented the occurrence of tubular necrosis and reduced the renal tubular damage scores markedly (1.85 +/- 0.06 vs. 3.63 +/- 0.06 scores, P < 0.01). In addition, M/M Phi infiltration was obviously suppressed (9.77 +/- 1.19 cells/ hpf vs. 29.22 +/- 1.94 cells/ hpf, P < 0.01), Moreover, results of reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry showed the up-regulation of monocyte chemoattractant protein-1 (MCP-1) and intercellular adhesion molecule-1 (ICAM-1) was greatly decreased, inducible nitric oxide synthase (iNOS) and endothelin-1 (ET-1) expression were also reduced, approaching levels observed in sham-operated animals. The data suggest that NF-kappaB decoy ODN treatment protects renal tissue from the effects of I/R injury and thus reduces the severity of ARF.Conclusion. These experiments demonstrated that NF-kappaB plays a critical role in renal I/R injury by reducing a series of inflammatory genes. NF-kappaB decoy ODN treatment reduces the renal dysfunction and damage associated with ischemic ARF. Therefore, in vivo transfection of NF-kappaB decoy ODN provides a new therapeutic strategy for ischemic ARF.

Activation of NF-κB and Regulation by Ubiquitin-Proteasome Pathway in the Aorta of Rats with Chronic Renal Failure

Expression Changes of NF-κB in Aorta of Rats with Chronic Renal Failure

Expressions of inflammatory cytokines in serum and aorta of rats with chronic renal failure

C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice

Effects of serum from chronic renal failure rats on endoplasmic reticulum stress and activation of activating transcription factor 4 of rat arterial smooth muscle cells cultured in vitro

Function of NKCC1 in the Aortic Fibrosis of Rats with Chronic Kidney Disease

Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia.

The Function Alterations of Calcium-activated Potassium Channel in Aortic Smooth Muscle of Chronic Renal Failure Rats

Both partial inactivation as well as activation of NF-κB signaling lead to hypertension and chronic kidney disease

Poricoic Acid A Inhibits the NF-κB/MAPK Pathway to Alleviate Renal Fibrosis in Rats with Cardiorenal Syndrome

The association between activation of the ERK1/2-NF-κB signaling pathway by TIMP2 expression and chronic renal allograft dysfunction in the CRAD rat model

Effect Of Chronic Renal Failure Medium On The Ubiquitin-Proteasome Pathway Of Arterial Muscle Cells

Effects of chronic renal failure rabbit serum on proliferation and nuclear factor kappa B activation of rabbit arterial smooth muscle cells

The Effect of NF-κB on Apoptosis of Renal Tubular Cells in Acute Kidney Injury Induced by Ischemia-Reperfusion in Mice

Effect of Kurarinone on Renal Tubular Epithelial Cell-Mesenchyma Trans-differentiation in Rats with Renal Interstitial Fibrosis

In Vivo Transfection of NF-κB Decoy Oligodeoxynucleotides Attenuate Renal Ischemia/reperfusion Injury in Rats

Therapeutic effect of MG-132 on chronic renal failure rats

Influence of Ulinastatin on Rats with Acute Necrotizing Pancreatitis Associated Lung Injury

Effects of Long Non-Coding RNA LINC00963 on Renal Interstitial Fibrosis and Oxidative Stress of Rats with Chronic Renal Failure via the Foxo Signaling Pathway

Effects of Fluvastatin on Expression of Nuclear Factor-κB in Renal Ischemia and Reperfusion Injury in Rats

Inhibition of RIP1-RIP3-mediated necroptosis attenuates renal fibrosis via Wnt3α/β-catenin/GSK-3β signaling in unilateral ureteral obstruction